Jager Pharma Advisory Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 30.55%
(FY 2022)
- Profit 26.03%
(FY 2022)
- Ebitda 24.57%
(FY 2022)
- Net Worth 124.34%
(FY 2022)
- Total Assets 116.43%
(FY 2022)
About Jager Pharma Advisory
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jaswinder Gill and Nikhila Singh serve as directors at the Company.
- CIN/LLPIN
U74999MH2020PTC335883
- Company No.
335883
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jan 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jager Pharma Advisory?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaswinder Gill  | Managing Director | 13-Jan-2020 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikhila Singh | Director | 13-Jan-2020 | Current |
Financial Performance of Jager Pharma Advisory.
Jager Pharma Advisory Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30.55% increase. The company also saw a substantial improvement in profitability, with a 26.03% increase in profit. The company's net worth Soared by an impressive increase of 124.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jager Pharma Advisory?
Unlock access to Jager Pharma Advisory's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jager Pharma Advisory?
Unlock and access historical data on people associated with Jager Pharma Advisory, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jager Pharma Advisory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jager Pharma Advisory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
